Log in to save to my catalogue

Homocysteine-targeting compounds as a new treatment strategy for diabetic wounds via inhibition of t...

Homocysteine-targeting compounds as a new treatment strategy for diabetic wounds via inhibition of t...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_10031211

Homocysteine-targeting compounds as a new treatment strategy for diabetic wounds via inhibition of the histone methyltransferase SET7/9

About this item

Full title

Homocysteine-targeting compounds as a new treatment strategy for diabetic wounds via inhibition of the histone methyltransferase SET7/9

Publisher

London: Nature Publishing Group UK

Journal title

Experimental and Molecular Medicine, 2022, 54(0), , pp.1-11

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

In hypoxia and hyperglycemia, SET7/9 plays an important role in controlling HIF-1α methylation and regulating the transcription of HIF-1α target genes, which are responsible for angiogenesis and wound healing. Here, we report the Ir(III) complex
Set7_1a
bearing acetonitrile (ACN) ligands as a SET7/9 methyltransferase inhibitor and HIF-1α stab...

Alternative Titles

Full title

Homocysteine-targeting compounds as a new treatment strategy for diabetic wounds via inhibition of the histone methyltransferase SET7/9

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_10031211

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_10031211

Other Identifiers

ISSN

2092-6413,1226-3613

E-ISSN

2092-6413

DOI

10.1038/s12276-022-00804-1

How to access this item